These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5029660)

  • 1. [Clinical studies on the action of Sadamin Polfa].
    Michal B; Beata B; Beata K; Hieronim L; Ryszard G; Andrzej P; Michal M; Boguslaw K
    Pol Tyg Lek; 1972 May; 27(19):716-8. PubMed ID: 5029660
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of Sadamin, Polfa].
    Lukjan H; Bielawiec M; Bogdanikowa B; Kiersnowska B; Korfel B; Dowzyk W
    Pol Tyg Lek; 1972 May; 27(20):739-40. PubMed ID: 5029663
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of Sadamin on some blood clotting parameters and fibrinolysis in patients with obliterative arteriosclerosis of lower limb arteries].
    Kiersnowska B; Bielawiec M; Lukjan H; Korfel B; Rogowski F; Dowzyk W
    Pol Tyg Lek; 1973 Mar; 28(11):400-3. PubMed ID: 4694796
    [No Abstract]   [Full Text] [Related]  

  • 4. [Electroretinographic control of the action of theophylline nicotinate on some vascular diseases of the retina].
    Cordella M; Vinciguerra E
    Ann Ottalmol Clin Ocul; 1967 Dec; 93(12):1267-80. PubMed ID: 5605983
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical valuation of "Plasmaclar", a new drug for the treatment of hyperlipaemias (author's transl)].
    Ferrer García JL
    Folia Clin Int (Barc); 1973 Nov; 23(11):782-94. PubMed ID: 4773216
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metabolic and circulatory effects of "Complamin" in arteriosclerosis patients].
    DuRuisseau JP; Laurendeau E
    Union Med Can; 1966 Oct; 95(10):1171-7. PubMed ID: 5920068
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of xanthinol nicotinate on the small blood vessels.
    Davis E; Rozov H
    Bibl Anat; 1973; 11():334-9. PubMed ID: 4789059
    [No Abstract]   [Full Text] [Related]  

  • 8. [The treatment of blood circulation disorders with an adenosine-theophylline sodium nicotinate combination].
    Hüdepohl M; Bockelmann R
    Med Klin; 1966 Feb; 61(5):184-6. PubMed ID: 5982907
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the treatment of hyperlipemia with theophylline nicotinate].
    Ciammaichella A
    Atti Soc Ital Cardiol; 1969 Jan; 2():251-60. PubMed ID: 5406537
    [No Abstract]   [Full Text] [Related]  

  • 10. [The therapy of peripheral circulatory disorders (angiooganopathies) with a blood extract].
    Schirren C; Dietrich K; Biel F
    Hautarzt; 1967 Jun; 18(6):260-4. PubMed ID: 5593511
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of hyperlipemia using xantinol-nicotinate].
    Möller-Hardenack B
    Med Monatsschr; 1973 Aug; 27(8):370-2. PubMed ID: 4756297
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
    Cascio F
    Minerva Cardioangiol; 1973 Nov; 21(11):715-31. PubMed ID: 4776567
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evaluation of xanthinol nicotinate ("complamin") in Nigerians with cerebral thrombosis.
    Dada TO
    West Afr Med J Niger Pract; 1971 Feb; 20(1):202-5. PubMed ID: 4930360
    [No Abstract]   [Full Text] [Related]  

  • 14. [Wallerox increases cerebral circulation and heart capacity].
    Heynen U
    Z Allgemeinmed; 1971 Dec; 47(34):1823-5. PubMed ID: 5003212
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical studies on Juston].
    Bornfleth GH; Lehrach F
    Med Monatsschr; 1975 Jan; 29(1):22-4. PubMed ID: 1091842
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and instrumental observations on the hemodynamic activity of a new drug: 7-(2-(3-pyridyl-methylamino)-ethyl)-theophylline nicotinate].
    Jovino R; Renda A
    Minerva Cardioangiol; 1971 Dec; 19(12):709-18. PubMed ID: 5129037
    [No Abstract]   [Full Text] [Related]  

  • 17. [Control of fat clearance insufficiency in hyperlipemic atherosclerosis].
    Zeller W; Christ F
    Med Klin; 1966 Jan; 61(4):136-9. PubMed ID: 5983158
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sadamin and Complamin in the treatment of coronary disease].
    Dubiel JP; Ciba T
    Pol Tyg Lek; 1970 Dec; 25(52):2038-40. PubMed ID: 5495547
    [No Abstract]   [Full Text] [Related]  

  • 19. [The action of xanthinol nicotinate on the peripheral circulation of the aged].
    Chevat H; Steenhouwer B; Hiltenbrand C; Legrand MF; Graux P
    Angeiologie; 1968; 20(2):33-42. PubMed ID: 5682235
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experience with Complamin in peripheral circulation disorders].
    Wittenburg H
    Med Monatsschr; 1969 Dec; 23(12):558-61. PubMed ID: 5387170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.